Sally John

Sally John is a seasoned professional in the field of informatics and predictive sciences, currently serving as Senior Vice President at Bristol Myers Squibb since September 2024. Between November 2017 and September 2024, Sally held multiple key positions at Biogen, including SVP Translational Sciences and VP Translational Biology, after previously serving as VP of Genomics and Computational Biology at Biogen Idec from August 2014 to January 2017. Prior experience includes roles at Pfizer, where Sally worked from January 2007 to August 2014 as Executive Director and Senior Director, and a tenure at the University of Manchester as Senior Lecturer and Deputy Director from February 2002 to January 2007. Earlier in career, Sally was a Team Leader at AstraZeneca from 1999 to 2001. Educational background includes a Doctor of Philosophy (PhD) in Immunology and Molecular Biology from The University of Manchester, obtained from 1989 to 1993.